Literature DB >> 17827956

Hepatitis C virus with normal transaminase levels.

Claudio Puoti1.   

Abstract

Approximately 30% of patients with chronic HCV infection show persistently normal alanine aminotransferase (PNALT) levels. The majority of these patients have some degree of histological liver damage. Controversies still exist regarding the definition of 'persistent' alanine aminotransferase (ALT) normality, and the natural history and optimal management of chronic hepatitis C with normal ALT. Although patients with HCV infection and normal ALT have been historically excluded from antiviral treatment, with the advent of the new treatment with PEG-interferon plus ribavirin, it has been suggested that the issue of whether or not to treat subjects with PNALT should be re-evaluated, and that antiviral treatment should be useful at least in selected subsets of patients. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827956     DOI: 10.1159/000103901

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  2 in total

1.  IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase.

Authors:  Tatsuo Miyamura; Tatsuo Kanda; Masato Nakamura; Xia Jiang; Shuang Wu; Shingo Nakamoto; Shigeru Mikami; Nobuo Takada; Fumio Imazeki; Osamu Yokosuka
Journal:  World J Hepatol       Date:  2013-11-27

2.  Difference in serum complement component C4a levels between hepatitis C virus carriers with persistently normal alanine aminotransferase levels or chronic hepatitis C.

Authors:  Kazuyuki Imakiire; Hirofumi Uto; Yuko Sato; Fumisato Sasaki; Seiichi Mawatari; Akio Ido; Kazuya Shimoda; Katsuhiro Hayashi; Sherri O Stuver; Yoshito Ito; Takeshi Okanoue; Hirohito Tsubouchi
Journal:  Mol Med Rep       Date:  2012-05-21       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.